More on PHIO

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+33.3% Growth)
- Ratings (10.0 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Phio Pharmaceuticals Corp. (NQ:PHIO)
Delayed: 1.04 -0.03 (2.8%)
Prev. Close $1.07  
Open$1.06 
52 Wk High$ 
52 Wk Low$ 
Day High$1.07 
Day Low$1.03 
P/E N/A  
EPS$ 
Volume85,108 

Friends, Peers and Foes (?): JUNS, JAGX, MTVA, ACCS, AREB (more...)

Jul 22, 2026 12:31 PM Correction to Announcement Regarding Phio Pharmaceuticals Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Jul 22, 2026 07:02 AM Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
Jul 21, 2026 07:08 AM Form 8-K Phio Pharmaceuticals For: Jul 21
Jul 21, 2026 07:01 AM Phio Pharmaceuticals adds dermatologist to its board of directors
Jul 21, 2026 07:01 AM Phio Pharmaceuticals Announces Appointment of Dr. R. Todd Plott to the Board of Directors
Jul 15, 2026 07:02 AM Phio Pharmaceuticals receives patent approvals in U.S., Canada, and Japan
Jul 15, 2026 07:02 AM Phio Pharmaceuticals Announces Patent Milestone with Multiple Notices of Allowance and Grant Decision
Jun 29, 2026 04:02 PM Form 4 Phio Pharmaceuticals For: Jun 26 Filed by: Bitterman Robert J
Jun 26, 2026 08:35 AM Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing
Jun 26, 2026 07:02 AM Phio Pharmaceuticals Announces Participation in the Renmark Financial Communications Live Virtual Non-Deal Roadshow Series
View All Articles

Entities mentioned with PHIO

View All Entities